Arca
Skip to content
Tools
Tools

Form FDA 2253 Helper

Drug companies must send FDA a copy of every ad and promotional piece when it is first used, with a cover form, Form FDA 2253. This page helps fill in that form correctly and shows where each file goes in the electronic submission.

Pick the drug to fill in its application from Drugs@FDA, or start with a blank form. Each field is checked against FDA's instructions for Form FDA 2253 and its guidance on electronic promotional submissions, and the summary shows where each part goes in eCTD module 1.

Form FDA 2253 fields

Everything you type stays in this browser tab.

Drug and application

1Application and productItems 1โ€“6 ยท 1 of 8 done
How to fill this
  • OPDP reviews CDER drugs and therapeutic biologics; APLB reviews CBER biologics.
  • Item 3: give the proprietary name with the dosage form if it is part of the name or tells this product from others with the same name.
  • Item 5: use the revision date printed on the package insert.
  • Multiple products covers price lists, formulary lists, multi-product reminder ads and corporate pieces. List the other applications one per line: application type and number, trade name, established name.
2MaterialsItem 7, one row per piece ยท 0 of 5 done
How to fill this
  • Use the most specific material type code; โ€œPromotional Labelingโ€ is the catch-all. Kits list each component on its own row.
  • For mixed audiences, pick the primary one and say so in the comments. Consumer and professional pieces go on separate forms.
  • Comments: how the piece is disseminated and any pieces it goes with.
3Applicant and signatureItems 8โ€“13 ยท 1 of 5 done
How to fill this
  • Item 8: the applicant's (or agent's) return address, including the country.
  • Item 10: the typed name and title of the person who answers FDA's questions about this submission. Sign the official form itself (item 11).
  • Item 13: leave Draft and Final unchecked for CDER (OPDP); for CBER (APLB) final postmarketing pieces, check Final only.

A checklist and summary, not the official form. Enter these on FDA's fillable Form FDA 2253 and sign it there.

Application numbers, product names and applicants are from FDA's Drugs@FDA data files; the date of the newest label from DailyMed. Drugs@FDA abbreviates applicant names, so use the manufacturer's full name on the form. Drugs@FDA and DailyMed

About the Form 2253 helper

What it follows

Frequently asked questions

Does this make the official form?
No. It produces a checklist and a plain-text summary of the fields. FDA requires its own current fillable Form FDA 2253, which you fill in and sign; this page helps you get the entries right before you do.
Is what I type stored?
No. The fields stay in this browser tab. Only the drug and application you pick are in the page address.
When is a 2253 due?
At the time of initial dissemination of promotional labeling and initial publication of an advertisement, with the product's current labeling (21 CFR 314.81(b)(3)(i) for drugs, 21 CFR 601.12(f)(4) for biologics). Since June 2021 these submissions must be electronic, in eCTD.
Where do the material type codes come from?
The 44 codes are the ones listed in FDA's instructions supplement for the form (11/21 edition). FDA's guidance asks for the most specific code that fits; โ€œPromotional Labelingโ€ is the catch-all.
Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.